Pharmacogenetics of the human MDR1 multidrug transporter

Current Pharmacogenomics

Volumn 2, Issue 1, 2004, Pages 1-11

  Lee, Caroline G ^a,b   Chong, Samuel S ^a,c   Lee, Edmund J D ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTIVIRUS AGENT; CARRIER PROTEIN; CEFAZOLIN; COLCHICINE; CYCLOSPORIN A; DACTINOMYCIN; DIGOXIN; DOXORUBICIN; ETOPOSIDE; FEXOFENADINE; GLYCOPROTEIN P; LOPERAMIDE; MITOMYCIN C; MULTIDRUG RESISTANCE PROTEIN 1; NORTRIPTYLINE; ONDANSETRON; PACLITAXEL; PHENOTHIAZINE; PRIMAQUINE; PROTEINASE INHIBITOR; PUROMYCIN; RESERPINE; TERFENADINE; UNINDEXED DRUG; VALINOMYCIN; VERAPAMIL; VINBLASTINE; VINCRISTINE; XENOBIOTIC AGENT;

AFRICAN AMERICAN; ASIAN; BEHAVIOR DISORDER; CAUCASIAN; CHINESE; DISEASE PREDISPOSITION; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; DRUG TRANSPORT; ETHNIC DIFFERENCE; FILIPINO; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GHANA; GRAFT REJECTION; HUMAN; HYPERTENSION; INDIAN; JAPAN; KENYA; KIDNEY TRANSPLANTATION; KIDNEY TUMOR; NONHUMAN; PARKINSON DISEASE; PHARMACOGENETICS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SUDAN; TISSUE DISTRIBUTION; ULCERATIVE COLITIS;

EID: 3042848593     PISSN: 15701603     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570160043476097     Document Type: Review

References (79)

1. Addess, K. J.; Basilion, J. P.; Klausner, R. D.; Rouault, T. A. and Pardi, A. (1997) Structure and Dynamics of the Iron Responsive Element RNA: Implications for Binding of the RNA by Iron Regulatory Binding Proteins. J. Mol. Biol. 274, 72-83.
2. Allain, F. H.; Gubser, C. C.; Howe, P. W.; Nagai, K.; Neuhaus, D. and Varani, G. (1996) Specificity of Ribonucleoprotein Interaction Determined by RNA Folding During Complex Formulation. Nature 380, 646-650.
3. Ameyaw, M. M.; Regateiro, F.; Li, T.; Liu, X.; Tariq, M.; Mobarek, A.; Thornton, N.; Folayan, G. O.; Githang'a, J.; Indalo, A.; Ofori-Adjei, D.; Price-Evans, D. A. and McLeod, H. L. (2001) MDR1 Pharmacogenetics: Frequency of the C3435T Mutation in Exon 26 is Significantly Influenced by Ethnicity. Pharmacogenetics 11, 217-221.
4. Azzaria, M.; Schurr, E. and Gros, P. (1989) Discrete Mutations Introduced in the Predicted Nucleotide-binding Sites of the mdr1 Gene Abolish its Ability to Confer Multidrug Resistance. Mol. Cell Biol. 9, 5289-5297.
5. Becquemont, L.; Verstuyft, C.; Kerb, R.; Brinkmann, U.; Lebot, M.; Jaillon, P. and Funck-Brentano, C. (2001) Effect of Grapefruit Juice on Digoxin Pharmacokinetics in Humans. Clin. Pharmacol. Ther. 70, 311-316.
6. Borst, P. and Schinkel, A. H. (1996) What Have We Learnt Thus Far from Mice with Disrupted P-glycoprotein Genes? Eur. J. Cancer 32A, 985-990.
7. Brinkmann, U. (2002) Functional Polymorphisms of the Human Multidrug Resistance (MDR1) gene: Correlation with P glycoprotein Expression and Activity Zn vivo. Novartis Found Symp. 243, 207-210.
8. Brinkmann, U. and Eichelbaum, M. (2001) Polymorphisms in the ABC Drug Transporter Gene MDR1. Pharmacogenomics J. 1, 59-64.
9. Brinkmann, U.; Roots, I. and Eichelbaum, M. (2001) Pharmacogenetics of the Human Drug-transporter Gene MDR1: Impact of Polymorphisms on Pharmacotherapy. Drug Discov. Today 6, 835-839.
10. Brookes, A. J. (1999) The Essence of SNPs. Gene 234, 177-186.
11. Calado, R. T.; Falcao, R. P.; Garcia, A. B.; Gabellini, S. M.; Zago, M. A. and Franco, R. F. (2002) Influence of Functional MDR1 Gene Polymorphisms on P-glycoprotein Activity in CD34+ Hematopoietic Stem Cells. Haematologica 87, 564-568.
12. Calado, R. T.; Franco, R. F.; Zago, M. A. and Falcao, R. P. (2002) MDR1 Gene C3435T Polymorphism and the Risk of Acquired Aplastic Anaemia. Br. J. Haematol. 117, 769.
13. Cardarelli, C. O.; Aksentijevich, I.; Pastan, I. and Gottesman, M. M. (1995) Differential Effects of P-glycoprotein Inhibitors on NIH3T3 Cells Transfected with Wild-type (G185) or Mutant (V185) Multidrug Transporters. Cancer Res. 55, 1086-1091.
14. Cargill, M.; Altshuler, D.; Ireland, J.; Sklar, P.; Ardlie, K.; Patil, N.; Shaw, N.; Lane, C. R.; Lim, E. P.; Kalyanaraman, N.; Nemesh, J.; Ziaugra, L.; Friedland, L.; Rolfe, A.; Warrington, J.; Lipshutz, R.; Daley, G. Q. and Lander, E. S. (1999) Characterization of Single-nucleotide Polymorphisms in Coding Regions of Human Genes. Nat. Genet. 22, 231-238.
15. Cascorbi, I.; Gerloff, T.; Johne, A.; Meisel, C.; Hoffmeyer, S.; Schwab, M.; Schaeffeler, E.; Eichelbaum, M.; Brinkmann, U. and Roots, I. (2001) Frequency of Single Nucleotide Polymorphisms in the P-glycoprotein Drug Transporter MDR1 Gene in White Subjects. Clin. Pharmacol. Ther. 69, 169-174.
16. Chen, C. J.; Clark, D.; Ueda, K.; Pastan, I.; Gottesman, M. M. and Roninson, I. B. (1990) Genomic Organization of the Human Multidrug Resistance (MDR1) Gene and Origin of P-glycoproteins. J. Biol. Chem. 265, 506-514.
17. Choi, K. H.; Chen, C. J.; Kriegler, M. and Roninson, I. B. (1988) An Altered Pattern of Cross-resistance in Multidrug-resistant Human Cells Results from Spontaneous Mutations in the mdr1 (P-glycoprotein) Gene. Cell 53, 519-529.
18. Coleman, T. P. and Roesser, J. R. (1998) RNA Secondary Structure: An Important Cis-element in Rat Calcitonin/CGRP Pre-messenger RNA Splicing. Biochemistry 37, 15941-15950.
19. Collins, F. S.; Brooks, L. D. and Chakravarti, A. (1998) A DNA Polymorphism Discovery Resource for Research on Human Genetic Variation [published erratum appears in Genome Res. 1999 Feb;9(2):210]. Genome Res. 8, 1229-1231.
20. Cox, D.; Boillot, C. and Canzian, F. (2001) Data Mining: Efficiency of Using Sequence Databases for Polymorphism Discovery. Hum. Mutat. 17, 141-150.
21. Dean, M.; Rzhetsky, A. and Allikmets, R. (2001) The Human ATP-binding Cassette (ABC) Transporter Superfamily. Genome Res. 11, 1156-1166.
22. Decleves, X.; Chevillard, S.; Charpentier, C.; Vielh, P. and Laplanche, J. L. (2000) A New Polymorphism (N21D) in the Exon 2 of the Human MDR1 Gene Encoding the P-glycoprotein. Hum. Mutat. 15, 486.
23. Drescher, S.; Schaeffeler, E.; Hitzl, M.; Hofmann, U.; Schwab, M.; Brinkmann, U.; Eichelbaum, M. and Fromm, M. F. (2002) MDR1 Gene Polymorphisms and Disposition of the P-glycoprotein Substrate Fexofenadine. Br. J. Clin. Pharmacol. 53, 526-534.
24. Dresser, M. J. (2001) The MDR1 C3435T Polymorphism: Effects on P-glycoprotein Expression/Function and Clinical Significance. AAPS Pharm. Sci. 3, 3.
25. Drozdzik, M.; Bialecka, M.; Mysliwiec, K.; Honczarenko, K.; Stankiewicz, J. and Sych, Z. (2003) Polymorphism in the P-glycoprotein Drug Transporter MDR1 Gene: A Possible Link Between Environmental and Genetic Factors in Parkinson's Disease. Pharmacogenetics 13, 259-263.
26. Fellay, J.; Marzolini, C.; Meadon, E.; Back, D.; Buclin, T.; Chave, J.; Decosterd, L.; Furrer, H.; Opravil, M.; Pantaleo, G.; Retelska, D.; Ruiz, L.; Schinkel, A.; Vernazza, P.; Eap, C. and Telenti, A. (2002) Response to Antiretroviral Treatment in HIV-1-infected Individuals with Allelic Variants of the Multidrug Resistance Transporter 1: A Pharmacogenetic Study. Lancet 359, 30-36.
27. Furuno, T.; Landi, M. T.; Ceroni, M.; Caporaso, N.; Bernucci, I.; Nappi, G.; Martignoni, E.; Schaeffeler, E.; Eichelbaum, M.; Schwab, M. and Zanger, U. M. (2002) Expression Polymorphism of the Blood-brain Barrier Component P-glycoprotein (MDR1) in Relation to Parkinson's Disease. Pharmacogenetics 12, 529-534.
28. Germann, U. A.; Chambers, T. C.; Ambudkar, S. V.; Licht, T.; Cardarelli, C. O.; Pastan, I. and Gottesman, M. M. (1996) Characterization of Phosphorylation-defective Mutants of Human P-glycoprotein Expressed in Mammalian Cells. J. Biol. Chem. 271, 1708-1716.
29. Germann, U. A.; Chambers, T. C.; Ambudkar, S. V.; Pastan, I. and Gottesman, M. M. (1995) Effects of Phosphorylation of P-glycoprotein on Multidrug Resistance. J. Bioenerg. Biomembr. 27, 53-61.
30. Gottesman, M. M.; Hrycyna, C. A.; Schoenlein, P. V.; Germann, U. A. and Pastan, I. (1995) Genetic Analysis of the Multidrug Transporter. Annu. Rev. Genet. 29, 607-649.
31. Gottesman, M. M. and Pastan, I. (1993) Biochemistry of Multidrug Resistance Mediated by the Multidrug Transporter. Annu. Rev. Biochem. 62, 385-427.
32. Guillaudeux, T.; Janer, M.; Wong, G. K.; Spies, T. and Geraghty, D. E. (1998) The Complete Genomic Sequence of 424,015 bp at the Centromeric End of the HLA Class I Region: Gene Content and Polymorphism. Proc. Natl. Acad. Sci. USA 95, 9494-9499.
33. Hafkemeyer, P.; Dey, S.; Ambudkar, S. V.; Hrycyna, C. A.; Pastan, I. and Gottesman, M. M. (1998) Contribution to Substrate Specificity and Transport of Nonconserved Residues in Transmembrane Domain 12 of Human P-glycoprotein. Biochemistry 37, 16400-16409.
34. Hitzl, M.; Drescher, S.; van der Kuip, H.; Schaffeler, E.; Fischer, J.; Schwab, M.; Eichelbaum, M. and Fromm, M. F. (2001) The C3435T Mutation in the Human MDR1 Gene is Associated with Altered Efflux of the P-glycoprotein Substrate Rhodamine 123 from CD56+ Natural Killer Cells. Pharmacogenetics 11, 293-298.
35. Hoffmeyer, S.; Burk, O.; von Richter, O.; Arnold, H. P.; Brockmoller, J.; Johne, A.; Cascorbi, I.; Gerloff, T.; Roots, I.; Eichelbaum, M. and Brinkmann, U. (2000) Functional Polymorphisms of the Human Multidrug-resistance Gene: Multiple Sequence Variations and Correlation of One Allele with P-glycoprotein Expression and Activity in vivo. Proc. Natl. Acad. Sci. USA 97, 3473-3478.
36. Hrycyna, C. A. (2001) Molecular Genetic Analysis and Biochemical Characterization of Mammalian P-glycoproteins Involved in Multidrug Resistance. Semin. Cell Dev. Biol. 12, 247-256.
37. Illmer, T.; Schuler, U. S.; Thiede, C.; Schwarz, U. I.; Kim, R. B.; Gotthard, S.; Freund, D.; Schakel, U.; Ehninger, G. and Schaich, M. (2002) MDR1 Gene Polymorphisms Affect Therapy Outcome in Acute Myeloid Leukemia Patients. Cancer Res. 62, 4955-4962.
38. Ito, S.; Ieiri, I.; Tanabe, M.; Suzuki, A.; Higuchi, S. and Otsubo, K. (2001) Polymorphism of the ABC Transporter Genes, MDR1, MRP1 and MRP2/cMOAT, in Healthy Japanese Subjects. Pharmacogenetics 11, 175-184.
39. Kao, S. L.; Chong, S. S. and Lee, C. G. (2000) The Role of Single Nucleotide Polymorphisms (SNPs) in Understanding Complex Disorders and Pharmacogenomics. Ann. Acad. Med. Singapore 29, 376-382.
40. Kennedy, M.; Roberts, R.; Mulder, R. and Joyce, P. (2001) A Common P-glycoprotein Polymorphism is Associated with Nortriptyline-induced Postural Hypotension in Patients Treated for Major Depression. In American Society of Human Genetics 51st Annual Meeting (San Diego, CA, USA) pp. 2350.
41. Kerb, R.; Aynacioglu, A. S.; Brockmoller, J.; Schlagenhaufer, R.; Bauer, S.; Szekeres, T.; Hamwi, A.; Fritzer-Szekeres, M.; Baumgartner, C.; Ongen, H. Z.; Guzelbey, P.; Roots, I. and Brinkmann, U. (2001) The Predictive Value of MDR1, CYP2C9, and CYP2C19 Polymorphisms for Phenytoin Plasma Levels. Pharmacogenomics J. 1, 204-210.
42. Kerb, R.; Hoffmeyer, S. and Brinkmann, U. (2001) ABC Drug Transporters: Hereditary Polymorphisms and Pharmacological Impact in MDR1, MRP1 and MRP2. Pharmacogenomics 2, 51-64.
43. Kim, R. B.; Fromm, M. F.; Wandel, C.; Leake, B.; Wood, A. J.; Roden, D. M. and Wilkinson, G. R. (1998) The Drug Transporter P-glycoprotein Limits Oral Absorption and Brain Entry of HIV-1 Protease Inhibitors. J. Clin. Invest. 101, 289-294.
44. Kim, R. B.; Leake, B. F.; Choo, E. F.; Dresser, G. K.; Kubba, S. V.; Schwarz, U. I.; Taylor, A.; Xie, H. G.; McKinsey, J.; Zhou, S.; Lan, L. B.; Schuetz, J. D.; Schuetz, E. G. and Wilkinson, G. R. (2001) Identification of Functionally Variant MDR1 Alleles among European Americans and African Americans. Clin. Pharmacol. Ther. 70, 189-199.
45. Kimchi-Sarfaty, C.; Gribar, J. J. and Gottesman, M. M. (2002) Functional Characterization of Coding Polymorphisms in the Human MDR1 Gene Using a Vaccinia Virus Expression System. Mol. Pharmacol. 62, 1-6.
46. Lee, C. G. and Gottesman, M. M. (1998) HIV-1 Protease Inhibitors and the MDR1 Multidrug Transporter [editorial]. J. Clin. Invest. 101, 287-288.
47. Lee, C. G.; Gottesman, M. M.; Cardarelli, C. O.; Ramachandra, M.; Jeang, K. T.; Ambudkar, S. V.; Pastan, I. and Dey, S. (1998) HIV-1 Protease Inhibitors are Substrates for the MDR1 Multidrug Transporter. Biochemistry 37, 3594-3601.
48. Liu, H. X.; Cartegni, L.; Zhang, M. Q. and Krainer, A. R. (2001) A Mechanism for Exon Skipping Caused by Nonsense or Missense Mutations in BRCA1 and Other Genes. Nat. Genet. 27, 55-58.
49. Liu, Y. and Hu, M. (2000) P-glycoprotein and Bioavailability-implication of Polymorphism. Clin. Chem. Lab. Med. 38, 877-881.
50. Min, D. I. and Ellingrod, V. L. (2002) C3435T Mutation in Exon 26 of the Human MDR1 Gene and Cyclosporine Pharmacokinetics in Healthy Subjects. Ther. Drug Monit. 24, 400-404.
51. Morita, N.; Yasumori, T. and Nakayama, K. (2003) Human MDR1 Polymorphism: G2677T/A and C3435T have No Effect on MDR1 Transport Activities. Biochemical Pharmacology 65, 1843-1852.
52. Nachman, M. W.; Bauer, V. L.; Crowell, S. L. and Aquadro, C. F. (1998) DNA Variability and Recombination Rates at X-linked Loci in Humans. Genetics 150, 1133-1141.
53. Nebert, D. W. (1999) Pharmacogenetics and Pharmacogenomics: Why is This Relevant to the Clinical Geneticist? Clin. Genet. 56, 247-258.
54. Nebert, D. W. (1997) Polymorphisms in Drug-metabolizing Enzymes: What is Their Clinical Relevance and Why do They Exist? [editorial; comment]. Am. J. Hum. Genet. 60, 265-271.
55. Potocnik, U.; Glavac, M. R.; Golouh, R. and Glavac, D. (2001) The Role of P-glycoprotein (MDR1) Polymorphisms and Mutations in Colorectal Cancer. Pflugers Arch. 442, R182-183.
56. Potocnik, U.; Ravnik-Glavac, M. and Glavac, D. (2002) Functional MDR1 Polymorphisms (G2677T and C3435T) and TCF4 Mutations in Colorectal Tumors with High Microsatellite Instability. Cell Mol. Biol. Lett. 7, 92-95.
57. Potocnik, U.; Ravnik-Glavac, M.; Golouh, R. and Glavac, D. (2002) Naturally Occurring Mutations and Functional Polymorphisms in Multidrug Resistance I Gene: Correlation with Microsatellite Instability and Lymphoid Infiltration in Colorectal Cancers. J. Med. Genet. 39, 340-346.
58. Roberts, R.; Joyce, P.; Mulder, R.; Begg, E. and Kennedy, M. (2002) A Common P-glycoprotein Polymorphism is Associated with Nortriptyline-induced Postural Hypotension in Patients Treated with Major Depression. Pharmacogenomics 2, 191-196.
59. Saito, S., Iida, A.; Sekine, A., Miura, Y.; Ogawa, C.; Kawauchi, S.; Higuchi, S. and Nakamura, Y. (2002) Three Hundred Twenty-six Genetic Variations in Genes Encoding Nine Members of ATP-binding Cassette, Subfamily B (ABCB/MDR/TAP), in the Japanese Population. J. Hum. Genet. 47, 38-50.
60. Sakaeda, T.; Nakamura, T.; Horinouchi, M.; Kakumoto, M.; Ohmoto, N.; Sakai, T.; Morita, Y.; Tamura, T.; Aoyama, N.; Hirai, M.; Kasuga, M. and Okumura, K. (2001) MDR1 Genotype-related Pharmacokinetics of Digoxin After Single Oral Administration in Healthy Japanese Subjects. Pharm. Res. 18, 1400-1404.
61. Schaeffeler, E.; Eichelbaum, M.; Brinkmann, U.; Penger, A.; Asante-Poku, S.; Zanger, U. M. and Schwab, M. (2001) Frequency of C3435T Polymorphism of MDR1 Gene in African People. Lancet 358, 383-384.
62. Schinkel, A. H.; Kemp, S.; Dolle, M.; Rudenko, G. and Wagenaar, E. (1993) N-glycosylation and Deletion Mutants of the Human MDR1 P-glycoprotein. J. Biol. Chem. 268, 7474-7481.
63. Schinkel, A. H.; Smit, J. J. M.; van Tellingen, O.; Beijnen, J. H.; Wagenaar, E.; van Deemter, L.; Mol, C. A. A. M.; van der Valk, M. A.; Robanus-Maandag, E. C.; te Riele, H. P. J.; Berns, A. J. M.; Borst, P. (1994) Disruption of the Mouse mdr1a P-glycoprotein Gene Leads to a Deficiency in the Blood-brain Barrier and to Increased Sensitivity to Drugs. Cell 77, 491-502.
64. Schinkel, A. H.; Wagenaar, E.; Mol, C. A. and van Deemter, L. (1996) P-glycoprotein in the Blood-brain Barrier of Mice Influences the Brain Penetration and Pharmacological Activity of Many Drugs. J. Clin. Invest. 97, 2517-2524.
65. Schuetz, E. and Strom, S. (2001) Promiscuous Regulator of Xenobiotic Removal. Nat. Med. 7, 536-537.
66. Schwab, M.; Schaeffeler, E.; Marx, C.; Fromm, M. F.; Kaskas, B.; Metzler, J.; Stange, E.; Herfarth, H.; Schoelmerich, J.; Gregor, M.; Walker, S.; Cascorbi, I.; Roots, I.; Brinkmann, U.; Zanger, U. M. and Eichelbaum, M. (2003) Association Between the C3435T MDR1 Gene Polymorphism and Susceptibility for Ulcerative Colitis. Gastroenterology 124, 26-33.
67. Shen, L. X.; Basilion, J. P. and Stanton, V. P., Jr. (1999) Single-nucleotide Polymorphisms can Cause Different Structural Folds of mRNA. Proc. Natl. Acad. Sci. USA 96, 7871-7876.
68. Shen, L. X. and Tinoco, I., Jr. (1995) The Structure of an RNA Pseudoknot That Causes Efficient Frameshifting in Mouse Mammary Tumor Virus. J. Mol. Biol. 247, 963-978.
69. Siddiqui, A.; Kerb, R.; Weale, M. E.; Brinkmann, U.; Smith, A.; Goldstein, D. B.; Wood, N. W. and Sisodiya, S. M. (2003) Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-transporter Gene ABCB1. N. Engl. J. Med. 348, 1442-1448.
70. Siegmund, W.; Ludwig, K.; Giessmann, T.; Dazert, P.; Schroeder, E.; Sperker, B.; Warzok, R.; Kroemer, H. K. and Cascorbi, I. (2002) The Effects of the Human MDR1 Genotype on the Expression of Duodenal P-glycoprotein and Disposition of the Probe Drug Talinolol. Clin. Pharmacol. Ther. 72, 572-583.
71. Siegsmund, M.; Brinkmann, U.; Schaffeler, E.; Weirich, G.; Schwab, M.; Eichelbaum, M.; Fritz, P.; Burk, O.; Decker, J.; Alken, P.; Rothenpieler, U.; Kerb, R.; Hoffmeyer, S. and Brauch, H. (2002) Association of the P-glycoprotein Transporter MDR1(C3435T) Polymorphism with the Susceptibility to Renal Epithelial Tumors. J. Am. Soc. Nephrol. 13, 1847-1854.
72. Synold, T. W.; Dussault, I. and Forman, B. M. (2001) The Orphan Nuclear Receptor SXR Coordinately Regulates Drug Metabolism and Efflux. Nat. Med. 7, 584-590.
73. Tanabe, M.; Ieiri, I.; Nagata, N.; Inoue, K.; Ito, S.; Kanamori, Y.; Takahashi, M.; Kurata, Y.; Kigawa, J.; Higuchi, S.; Terakawa, N. and Otsubo, K. (2001) Expression of P-glycoprotein in Human Placenta: Relation to Genetic Polymorphism of the Multidrug Resistance (MDR)-1 Gene. J. Pharmacol. Exp. Ther. 297, 1137-1143.
74. Tang, K.; Ngoi, S. M.; Gwee, P. C.; Chua, J. M. Z.; Lee, E. J. D.; Chong, S. S. and Lee, C. G. L. (2002) Distinct Haplotype Profiles and Strong Linkage Disequilibrium at the MDR1 Multidrug Transporter Gene Locus in Three Ethnic Asian Populations. Pharmacogenetics 12, 437-450.
75. Ueda, K.; Clark, D. P.; Chen, C. J.; Roninson, I. B.; Gottesman, M. M. and Pastan, I. (1987) The Human Multidrug Resistance (mdr1) Gene. cDNA Cloning and Transcription Initiation. J. Biol. Chem. 262, 505-508.
76. Ueda, K.; Pastan, I. and Gottesman, M. M. (1987) Isolation and Sequence of the Promoter Region of the Human Multidrug- resistance (P-glycoprotein) Gene. J. Biol. Chem. 262, 17432-17436.
77. van den Heuvel-Eibrink, M. M.; Wiemer, E. A.; de Boevere, M. J.; van der Holt, B.; Vossebeld, P. J.; Pieters, R. and Sonneveld, P. (2001) MDR1 Gene-related Clonal Selection and P-glycoprotein Function and Expression in Relapsed or Refractory Acute Myeloid Leukemia. Blood 97, 3605-3611.
78. von Ahsen, N.; Richter, M.; Grupp, C.; Ringe, B.; Oellerich, M. and Armstrong, V. W. (2001) No Influence of the MDR-1 C3435T Polymorphism or a CYP3A4 Promoter Polymorphism (CYP3A4-V allele) on Dose-adjusted Cyclosporin A Trough Concentrations or Rejection Incidence in Stable Renal Transplant Recipients. Clin. Chem. 47, 1048-1052.
79. Wada, M.; Taniguchi, S.; Ebihara, T.; Nakamura, T.; Uchiumi, T. and Kuwano, M. (2002) [Genetic Polymorphism of Efflux Drug Transporters and Their Role in Drug Sensitivity]. Fukuoka Igaku Zasshi 93, 29-37.